Back to Journals » ImmunoTargets and Therapy » Volume 9
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators?
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,326 | Dovepress* | 4,130 | 827 | 4,957 | |
PubMed Central* | 196 | 80 | 276 | ||
Totals | 4,326 | 907 | 5,233 | ||
*Since 5 October 2020 |
View citations on PubMed and Google Scholar